Citations

Mayo Clinic

Showing 10 of 108523 citations.

Partner support and anxiety in young women with breast cancer
Borstelmann, Nancy A. , Rosenberg, Shoshana M. , Ruddy, Kathryn J. , Gelber, Shari , Schapira, Lidia , Come, Steven E. , Morgan, Evan , Tamimi, Rulla M. , Borges, Virginia F. , Partridge, Ann H.

Psycho-Oncology | March 13, 2015 | Volume: 24 | Issue: 12 | Pages: 1679-1685

10.1002/pon.3780 | PMID 25765893 Get It

AbstractObjectiveUsing a large prospective cohort of women age 40 or younger diagnosed with breast cancer, we examined the relationship between perceived partner support and anxiety.MethodsSix hundred seventy‐five young women with breast cancer Stages I–III, median age 36, completed a self‐report baseline questionnaire. Perceived partner support was assessed using items extracted from the marital subscale of the Cancer Rehabilitation Evaluation System; generalized social support was assessed with the Medical Outcomes Study–Social Support Survey. Anxiety was measured using the anxiety subscale of the Hospital Anxiety and Depression Scale. Multivariable logistic regression analyses evaluated the association between partner support, other sociodemographic factors, and anxiety.ResultsMean age at diagnosis was 35.4 years. Fourteen percent of the women were not partnered, and among those who were partnered or in a significant relationship, 20% were categorized as unsupported. In univariate and multivariable analysis adjusting for sociodemographic factors, women in an unsupported‐partnered relationship had higher odds of anxiety symptoms compared with women in a supported‐partnered relationship. Young age and being financially insecure were also both independently associated with anxiety.ConclusionsOur findings suggest that partner support may play a key role in a young woman's adjustment to a serious stressor such as breast cancer. In addition, younger age increases vulnerability to anxiety as does struggling with finances. Because supportive efforts of a partner have potential to protect against the impact of stress, interventions to enhance partner support and reduce anxiety might be beneficial to address challenges experienced as a couple in this setting. Copyright © 2015 John Wiley & Sons, Ltd.
Clozapine therapy throughout myelosuppressive chemotherapy: regulations without standardization
Barreto, Jason N. , Leung, Jonathan G. , Philbrick, Kemuel L. , Rasmussen, Keith G., Thompson, Carrie A. , Leung, Jonathan G

Psycho-Oncology | March 13, 2015 | Volume: 24 | Issue: 11 | Pages: 1581-1585

10.1002/pon.3779 | PMID 25765766 Get It

Neuromyelitis optica phenotype associated with therapy-responsive acute peripheral neuropathy
Feyissa, Anteneh M. , Shanina, Elena , Smith, Robert G., Shah, Rahul, Shah, Rahul , Feyissa, A M

Neurology Neuroimmunology & Neuroinflammation | March 13, 2015 | Volume: 2 | Issue: 3 | Pages: No page available

10.1212/nxi.0000000000000083 | PMID 25798448 Get It

High-Resolution Imaging of Upper Limb Neuropathies
Spinner, Robert J. , Felmlee, Joel P. , Amrami, Kimberly K. , Howe, Benjamin M. , Howe, Benjamin Matthew

Seminars in Musculoskeletal Radiology | March 12, 2015 | Volume: 19 | Issue: 02 | Pages: 160-167

10.1055/s-0035-1545078 | PMID 25764240 Get It

Diagnostic accuracy study of anorectal manometry for diagnosis of dyssynergic defecation
Grossi, Ugo , Carrington, Emma V. , Bharucha, Adil E. , Horrocks, Emma J, Scott, S. Mark , Knowles, Charles H.

Gut | March 12, 2015 | Volume: 65 | Issue: 3 | Pages: 447-455

10.1136/gutjnl-2014-308835 | PMID 25765461 Get It

Objective The diagnostic accuracy of anorectal manometry (AM), which is necessary to diagnose functional defecatory disorders (FDD), is unknown. Using blinded analysis and standardised reporting of diagnostic accuracy, we evaluated whether AM could discriminate between asymptomatic controls and patients with functional constipation (FC). Design Derived line plots of anorectal pressure profiles during simulated defecation were independently analysed in random order by three expert observers blinded to health status in 85 women with FC and 85 age-matched asymptomatic healthy volunteers (HV). Using accepted criteria, these pressure profiles were characterised as normal (ie, increased rectal pressure coordinated with anal relaxation) or types I–IV dyssynergia. Interobserver agreement and diagnostic accuracy were determined. Results Blinded consensus-based assessment disclosed a normal pattern in 16/170 (9%) of all participants and only 11/85 (13%) HV. The combined frequency of dyssynergic patterns (I–IV) was very similar in FC (80/85 (94%)) and HV (74/85 (87%)). Type I dyssynergia (‘paradoxical’ contraction) was less prevalent in FC (17/85 (20%) than in HV (31/85 (36.5%), p=0.03). After statistical correction, only type IV dyssynergia was moderately useful for discriminating between FC (39/85 (46%)) and HV (17/85 (20%)) (p=0.001, positive predictive value=70.0%, positive likelihood ratio=2.3). Interobserver agreement was substantial or moderate for identifying a normal pattern, dyssynergia types I and IV, and FDD, and fair for types II and III. Conclusions While the interpretation of AM patterns is reproducible, nearly 90% of HV have a pattern that is currently regarded as ‘abnormal’ by AM. Hence, AM is of limited utility for distinguishing between FC and HV.
GermlineTP53Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry
Yurgelun, Matthew B. , Masciari, Serena, Joshi, Victoria A., Mercado, Rowena, Lindor, Noralane M. , Gallinger, Steven , Jenkins, Mark A. , Buchanan, Daniel D. , Haile, Robert W. , Kucherlapati, Raju, Hopper, John L. , Newcomb, Polly A. , Potter, John D. , Syngal, Sapna , Buchanan, Daniel D , Jenkins, Mark A , Haile, Robert W

JAMA Oncology | March 12, 2015 | Volume: 1 | Issue: 2 | Pages: 214

10.1001/jamaoncol.2015.0197 | PMID 26086041 Get It

Myeloproliferative Neoplasms
Tefferi, Ayalew , Pardanani, Animesh

JAMA Oncology | March 12, 2015 | Volume: 1 | Issue: 1 | Pages: 97

10.1001/jamaoncol.2015.89 | PMID 26182311 Get It

Decision aids for localized prostate cancer treatment choice: Systematic review and meta‐analysis
Violette, Philippe D. , Agoritsas, Thomas , Alexander, Paul , Riikonen, Jarno , Santti, Henrikki , Agarwal, Arnav , Bhatnagar, Neera , Montori, Víctor M. , Tikkinen, Kari A.O. , Agarwal, Arnav , Dahm, Philipp , Guyatt, Gordon , Montori, Victor M

CA: A Cancer Journal for Clinicians | March 12, 2015 | Volume: 65 | Issue: 3 | Pages: 239-251

10.3322/caac.21272 | PMID 25772796 Get It

Abstract Patients who are diagnosed with localized prostate cancer need to make critical treatment decisions that are sensitive to their values and preferences. The role of decision aids in facilitating these decisions is unknown. The authors conducted a systematic review of randomized trials of decision aids for localized prostate cancer. Teams of 2 reviewers independently identified, selected, and abstracted data from 14 eligible trials (n = 3377 men), of which 10 were conducted in North America. Of these, 11 trials compared decision aids with usual care, and 3 trials compared decision aids with other decision aids. Two trials suggested a modest positive impact on decisional regret. Results across studies varied widely for decisional conflict (4 studies), satisfaction with decision (2 studies), and knowledge (2 studies). No impact on treatment choices was observed (6 studies). In conclusion, scant evidence at high risk of bias suggests the variable impact of existing decision aids on a limited set of decisional processes and outcomes. Because current decision aids provide information but do not directly facilitate shared decision making, subsequent efforts would benefit from user‐centered design of decision aids that promote shared decision making. CA Cancer J Clin 2015;65: 239–251. © 2015 American Cancer Society.
Long‐term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder
Kaushik, Dharam , Frank, Igor, Boorjian, Stephen A. , Cheville, John C. , Eisenberg, Manuel S., Thapa, Prabin , Tarrell, Robert F., Thompson, R. Houston

International Journal of Urology | March 12, 2015 | Volume: 22 | Issue: 6 | Pages: 549-554

10.1111/iju.12729 | PMID 25761779 Get It

ObjectiveTo review our experience with radical cystectomy for small cell carcinoma of the bladder, to compare outcomes with a cohort of patients with urothelial carcinoma, and to determine the effect of adjuvant chemotherapy and pathology re‐review in this setting.MethodsAmong 2427 patients who underwent radical cystectomy, 68 patients had small cell carcinoma of the bladder. Patients with small cell carcinoma of the bladder were compared with an unmatched cohort of 1146 patients with urothelial carcinoma, and were then matched (1:2) based on TNM stage. Survival was estimated using the Kaplan–Meier method, and Cox models were used to evaluate association of clinicopathological features with outcome.ResultsAmong the 68 small cell carcinoma of the bladder patients, 37 (54%) were found to have small cell carcinoma of the bladder only after pathology re‐review. Patients with small cell carcinoma of the bladder had a higher rate of advanced (pT3/4) tumor stage (84% vs 46%; P < 0.0001) and pN+ disease (37% vs 20%; P = 0.001) compared with patients with urothelial carcinoma. When matched for stage and lymph node status, no significant difference in 5‐year cancer‐specific survival was observed between the two groups (27% vs 29%; P = 0.64). Among small cell carcinoma of the bladder patients, those receiving adjuvant chemotherapy had improved 5‐year overall survival compared with patients who did not receive adjuvant chemotherapy (43% vs 20%; P = 0.03), and a trend toward superior cancer‐specific survival (40% vs 23%; P = 0.07).ConclusionsSmall cell carcinoma of the bladder is often an unrecognized pathological entity, which is associated with a higher rate of locally advanced and N+ disease. However, although when matched for pathological features, survival outcomes appear similar to urothelial carcinoma. Small cell carcinoma of the bladder patients receiving adjuvant chemotherapy had improved overall survival and cancer‐specific survival, and these results require further investigation.
Association of hospitalization with long-term cognitive and brain MRI changes in the ARIC cohort
Brown, Charles H. , Sharrett, A. Richey, Schneider, Andrea L.C. , Coresh, Josef , Alonso, Álvaro , Knopman, David S. , Mosley, Thomas H. , Gottesman, Rebecca F. , Schneider, Andrea L C

Neurology | March 12, 2015 | Volume: 84 | Issue: 14 | Pages: 1443-1453

10.1212/wnl.0000000000001439 | PMID 25762715 Get It